Somanetics Corporation (NASDAQ: SMTS) focuses on developing, manufacturing and marketing the INVOS® Cerebral/Somatic Oximeter. This non-invasive patient monitoring system constantly measures changes in the blood oxygen levels in patients with or at risk for restricted blood flow. The INVOS System also provides the information necessary to identify oxygen imbalances in tissues beneath the sensor, allowing medical professionals to take corrective action. For further information, visit the Company’s web site at www.somanetics.com.
- 18 years ago
QualityStocks
Somanetics Corporation (NASDAQ: SMTS)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Why TruGolf Holdings Inc. (NASDAQ: TRUG) Is ‘One to Watch’
TruGolf (NASDAQ: TRUG) is pursuing a strategic expansion into blockchain-based financial infrastructure through its pending…
-
QualityStocksNewsBreaks – Versus Systems Inc. (NASDAQ: VS) Brings Interactive Experiences to Major Sports and Entertainment Audiences
Versus Systems (NASDAQ: VS) uses gamification and audience engagement technology to help brands, sports teams,…
-
QualityStocksNewsBreaks – BOXABL Inc. (NASDAQ: BXBL) Builds Momentum with Potential 1,500-Home Pipeline
BOXABL (NASDAQ: BXBL) has signed a multiyear purchase agreement with LC Vegas Acquisitions, LLC for…